Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...

Pfizer Inc's experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus that has killed over a ...

Pfizer is expected to report its third-quarter results next month, and analysts are projecting a double-digit decline in its ...

Shares in Pfizer fell on Monday after rival drugmaker Moderna said its experimental vaccine against COVID-19 was 94.5% effective and that it can be stored at normal fridge temperatures.

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

A new study shows that receiving an updated COVID vaccine reduced people’s risk of severe disease and death in all age groups ...

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

The CDC’s vaccine advisory panel has revealed more details about its plans to establish a work group to review the childhood ...

The market for VZV infection treatment is driven by increased vaccination and antiviral use, rising elderly populations, and strong immunization programs in developed regions. Key opportunities ...

Covid-19 has infected more than 236M people and killed over 4.8M globally. Here are the virus-related developments for October 6: ...